| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 8010 | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 6053* | 2016 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 4043* | 2015 |
| Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015 GA Roth, C Johnson, A Abajobir, F Abd-Allah, SF Abera, G Abyu, ... Journal of the American college of cardiology 70 (1), 1-25, 2017 | 4039 | 2017 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 3150 | 2021 |
| Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 CO Johnson, M Nguyen, GA Roth, E Nichols, T Alam, D Abate, ... The Lancet Neurology 18 (5), 439-458, 2019 | 2461 | 2019 |
| Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, ... The Lancet Neurology 18 (5), 459-480, 2019 | 2425* | 2019 |
| Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 VL Feigin, AA Abajobir, KH Abate, F Abd-Allah, AM Abdulle, SF Abera, ... The Lancet Neurology 16 (11), 877-897, 2017 | 1557 | 2017 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the … NJ Kassebaum, M Arora, RM Barber, ZA Bhutta, J Brown, A Carter, ... The Lancet 388 (10053), 1603-1658, 2016 | 1035 | 2016 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1023 | 2022 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 877 | 2017 |
| Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of … H Wang, ZA Bhutta, MM Coates, M Coggeshall, L Dandona, K Diallo, ... The Lancet 388 (10053), 1725-1774, 2016 | 847 | 2016 |
| Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 SS Lim, K Allen, ZA Bhutta, L Dandona, MH Forouzanfar, N Fullman, ... The Lancet 388 (10053), 1813-1850, 2016 | 666 | 2016 |
| Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the … RM Barber, N Fullman, RJD Sorensen, T Bollyky, M McKee, E Nolte, ... The lancet 390 (10091), 231-266, 2017 | 494 | 2017 |
| Medical and environmental risk factors associated with frontotemporal dementia: A case-control study in a veteran population YV Kalkonde, A Jawaid, SU Qureshi, P Shirani, M Wheaton, ... Alzheimer's and Dementia, 2012 | 117 | 2012 |
| Stroke systems of care in low-income and middle-income countries: challenges and opportunities JD Pandian, Y Kalkonde, IA Sebastian, C Felix, G Urimubenshi, J Bosch The Lancet 396 (10260), 1443-1451, 2020 | 105 | 2020 |
| The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis MP Quinones, CA Estrada, Y Kalkonde, SK Ahuja, WA Kuziel, M Mack, ... Journal of molecular medicine 83, 672-681, 2005 | 94 | 2005 |
| Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study C Ke, R Gupta, D Xavier, D Prabhakaran, P Mathur, YV Kalkonde, ... The Lancet Global Health 6 (8), e914-e923, 2018 | 92 | 2018 |
| Stroke prevention strategies in the developing world YV Kalkonde, S Alladi, S Kaul, V Hachinski Stroke 49 (12), 3092-3097, 2018 | 87 | 2018 |
| Chemokines in the MPTP model of Parkinson’s disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration YV Kalkonde, WW Morgan, J Sigala, SK Maffi, C Condello, W Kuziel, ... Brain research 1128, 1-11, 2007 | 82 | 2007 |
